Recruiting
Enterococcal infection
RecruitingEffectiveness and Safety of INTESTIFIX in Removing Vancomycin‑Resistant Enterococci Colonization in Immunocompromised Patients – drug combination
Registered drug
Effectiveness and Safety of INTESTIFIX in Removing Vancomycin‑Resistant Enterococci Colonization in Immunocompromised Patients – drug combination
Registered drug
- Disease:Enterococcal infection
- Substances:Ascorbic AcidMacrogol 3350+4
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Ascorbic Acid
- Sponsor:Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
